Senaste uppdateringen :
19/11/2024
forskargrupper - Faculty of pharmacy, State university of Utrecht   pdf  
Nederländerna
universitet
Faculty of pharmacy, State university of Utrecht
Utrecht
Hänvisningar   Hänvisningar   (15)  
1
Stability of oxaliplatin in chloride-containing carrier solutions used in hyperthermic intraperitoneal chemotherapy.
Mehta A.M,.Van den Hoven J.M, Rosing H,.Hillebrand M.J.X, Nuijen B,. Huitema A.D.R, Beijnen J.H,.Verwaal V.J. (a.mehta@nki.nl)
Int J Pharm - 2015 - ; 479 : 23-27.
2
Chemical stability of the cardioprotective agent ICRF-187 in infusion fluids.
Beijnen JH, Van Gijn R. ()
J Parenter Sci Technol - 1993 - ; 47: 166-171.
3
Degradation kinetics of the antitumor drug nimustin (ACNU) in aqueous solution.
Van der Houwen, O.AG.J, Beijnen J.H, Bult A, Bekers O, Goossen R.M.J, Underberg W.J.M. ()
Int J Pharm - 1993 - ; 99: 73-78.
4
Chemical stability of two sterile, parenteral formulations of cyclophosphamide (Endoxan) after reconstitution and dilution in commonly used infusion fluids.
Beijnen JH, van Gijn R, Challa EE, Kaijser GP, Underberg WJM. ()
J Parenter Sci Technol - 1992 - ; 46: 111-116.
5
Chemical and physical stability of etoposide and teniposide in commonly used infusion fluids.
Beijnen JH, Beijnen-Bandhoe U, Dubbelman AC, Van Gijn R, Underberg WJM. ()
J Parenter Sci Technol - 1991 - ; 45: 108-112.
6
Chemical stability of suramin in commonly used infusion fluids.
Beijnen JH, Van Gijn R, Horenblas S, Underberg WJM. ()
Ann Pharmacotherapy - 1990 - ; 24: 1056-1058.
7
Chemical stability of the antitumor mitomycin C in solutions for intravesical instillation.
Beijnen JH, Van Gijn R, Underberg WJM. ()
J Parenter Sci Technol - 1990 - ; 44: 332-335.
8
Stability of vinca alkaloid anticancer drugs in three commonly used infusion fluids.
Beijnen JH, Vendrig DEMM, Underberg WJM. ()
J Parenter Sci Technol - 1989 - ; 43: 84-87.
9
Degradation kinetics of vinblastine sulphate in aqueous solutions.
Vendrig DEMM, Smeets BPGM, Beijnen JH, van der Houwen OAGJ, Holthuis JJM. ()
Int J Pharm - 1988 - ; 43: 131-138.
10
Adsorption of human and porcin insulins to intravenous administration sets.
Tol A, Quik RFP, Thyssen JHH. ()
Pharm Weekbl [Sci] - 1988 - ; 10: 213-216.
11
Stability of intravenous admixtures of doxorubicin and vincristine.
Beijnen JH, Neef C, Meuwissen OJAT, Rutten JJMH, Rosing H, Underberg WJM. ()
Am J Hosp Pharm - 1986 - ; 43: 3022-3027.
12
Aspects of the degradation kinetics of doxorubicin in aqueous solution.
Beijnen JH, van der Houwen OAGJ, Underberg WJM. ()
Int J Pharm - 1986 - ; 32: 123-131.
14
Stability after freezing and thawing of solutions of mitomycin C in plastic minibags for intravesical use.
Stolk LML, Fruijtier A, Umans . ()
Pharm Weekbl [Sci] - 1986 - ; 8: 286-288.
15
Stability of anthracycline antitumour agents in infusion fluids.
Beijnen JH, Rosing H, De Vries PA, Underberg WJM. ()
J Parenter Sci Technol - 1985 - ; 39: 220-222.

 Förteckning över substanser   molekyler Studerade   (16)  
cancerläkemedel injektion Cyclophosphamide
cancerläkemedel injektion Daunorubicin hydrochloride
Cytoprotector injektion Dexrazoxane hydrochloride
cancerläkemedel injektion Doxorubicin hydrochloride
cancerläkemedel injektion Epirubicin hydrochloride
cancerläkemedel injektion Etoposide
cancerläkemedel injektion Idarubicin hydrochloride
Glukosnedsättande injektion Insulin
cancerläkemedel injektion Mitomycin
cancerläkemedel injektion Nimustine
cancerläkemedel injektion Oxaliplatin
Antiparasitärt medel injektion Suramin
cancerläkemedel injektion Teniposide
cancerläkemedel injektion Vinblastine sulfate
cancerläkemedel injektion Vincristine sulfate
cancerläkemedel injektion Vindesine sulfate

  Mentions Légales